Samy Tadros
Corporate Officer/Principal en TANGO THERAPEUTICS, INC. .
Perfil
Samy Tadros is currently the Head of Business Development at Tango Therapeutics, Inc. Prior to his current position, he worked at Celgene Corp.
as the Executive Director of Business Development from 2009 to 2020.
Mr. Tadros holds an undergraduate degree from Concordia University Chicago, an MBA from Fairleigh Dickinson University, and a graduate degree from Temple University School of Pharmacy.
Cargos activos de Samy Tadros
| Empresas | Cargo | Inicio |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Samy Tadros.
| Empresas | Cargo | Fin |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/04/2020 |
Formación de Samy Tadros.
| Concordia University Chicago | Undergraduate Degree |
| Temple University School of Pharmacy | Graduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TANGO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Samy Tadros
